Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers

Chaperones are the primary regulators of the proteostasis network and are known to facilitate protein folding, inhibit protein aggregation, and promote disaggregation and clearance of misfolded aggregates inside cells. We have tested the effects of five chaperones on the toxicity of misfolded oligomers preformed from three different proteins added extracellularly to cultured cells. All the chaperones were found to decrease oligomer toxicity significantly, even at very low chaperone/protein molar ratios, provided that they were added extracellularly rather than being overexpressed in the cytosol. Infrared spectroscopy and site-directed labeling experiments using pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers and chaperones. Moreover, atomic force microscopy imaging indicated that larger assemblies of oligomers are formed in the presence of the chaperones. This suggests that the chaperones bind to the oligomers and promote their assembly into larger species, with consequent shielding of the reactive surfaces and a decrease in their diffusional mobility. Overall, the data indicate a generic ability of chaperones to neutralize extracellular misfolded oligomers efficiently and reveal that further assembly of protein oligomers into larger species can be an effective strategy to neutralize such extracellular species.

[1]  F. Chiti,et al.  A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells , 2011, Journal of cellular and molecular medicine.

[2]  Andreas Bracher,et al.  Molecular chaperones in protein folding and proteostasis , 2011, Nature.

[3]  H. Kampinga,et al.  Identification of the Drosophila Ortholog of HSPB8 , 2010, The Journal of Biological Chemistry.

[4]  Glyn L. Devlin,et al.  The Interaction of αB-Crystallin with Mature α-Synuclein Amyloid Fibrils Inhibits Their Elongation , 2010, Biophysical journal.

[5]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[6]  C. Dobson,et al.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip , 2009, The EMBO journal.

[7]  F. Hartl,et al.  The role of molecular chaperones in human misfolding diseases , 2009, FEBS letters.

[8]  R. Morimoto,et al.  Biological and chemical approaches to diseases of proteostasis deficiency. , 2009, Annual review of biochemistry.

[9]  R. Morimoto,et al.  Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. , 2008, Genes & development.

[10]  M. Stefani,et al.  Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity , 2008, Journal of Molecular Medicine.

[11]  Mark R. Wilson,et al.  Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. , 2008, Biochemistry.

[12]  C. Dobson,et al.  The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Fabrizio Chiti,et al.  Prevention of amyloid‐like aggregation as a driving force of protein evolution , 2007, EMBO reports.

[14]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[15]  J. Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[16]  Jimena Weibezahn,et al.  Novel insights into the mechanism of chaperone-assisted protein disaggregation , 2005, Biological chemistry.

[17]  M. Rybchyn,et al.  The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. , 2005, Biochemistry.

[18]  Robert E. Cohen,et al.  Proteasomes and their kin: proteases in the machine age , 2004, Nature Reviews Molecular Cell Biology.

[19]  D. Selkoe Folding proteins in fatal ways , 2003, Nature.

[20]  T. Morgan,et al.  Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.

[21]  L. Fumagalli,et al.  Role of α2‐macroglobulin in regulating amyloid β‐protein neurotoxicity: protective or detrimental factor? , 2001 .

[22]  H. Kampinga,et al.  In Vivo Chaperone Activity of Heat Shock Protein 70 and Thermotolerance , 1999, Molecular and Cellular Biology.

[23]  S. Paul,et al.  α2‐Macroglobulin Attenuates β‐Amyloid Peptide 1–40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical Neurons , 1998 .

[24]  P. May,et al.  Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity , 1996 .

[25]  Steven A. Johnson,et al.  Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress , 1995, Experimental Neurology.

[26]  M. Wilson,et al.  Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. , 1992, Biochimica et biophysica acta.

[27]  Mark R. Wilson,et al.  Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. , 2008, Molecular bioSystems.